Standard BioTools Inc. (LAB)
NASDAQ: LAB
· Real-Time Price · USD
1.25
-0.04 (-3.10%)
At close: Sep 04, 2025, 11:11 AM
-3.10% (1D)
| Bid | 0.89 |
| Market Cap | 479.4M |
| Revenue (ttm) | 154.24M |
| Net Income (ttm) | -120.5M |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -3.39 |
| Forward PE | -8.27 |
| Analyst | Hold |
| Ask | 1.6 |
| Volume | 249,162 |
| Avg. Volume (20D) | 1,773,535 |
| Open | 1.28 |
| Previous Close | 1.29 |
| Day's Range | 1.25 - 1.28 |
| 52-Week Range | 0.92 - 2.32 |
| Beta | 1.32 |
Analyst Forecast
According to 0 analyst ratings, the average rating for LAB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Standard BioTools Inc. is scheduled to release its earnings on
Oct 29, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+17.14%
Standard BioTools shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
-3.77%
LAB stock has given up its prior gain. Standard BioTools shares were trading higher after the company reported better-than-expected Q1 sales results.
